|
Billam AG was established
in 2000 as a specialist investment vehicle, with particular interests
in the convergence of digital and bio technologies where opportunities
for rational design, discovery and control are addressed in computer
based models. In September 2003 the
entire share capital of Billam AG, based in Switzerland, was acquired
by Centurion Science.
|
|
Billam AG Investment Strategy is clearly
focused on Early Stage Research Projects and Quoted Growth Stocks
where, key to its Policy of Synergistic Investing, it embraces the
opportunities that convergent areas of scientific research potentially
present to investee companies within its Portfolio.
|